We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Drug Delivery

Article   Dec 04, 2020 | by Laura Elizabeth Lansdowne, Science Writer, Technology Networks

 
Drug Delivery
 
 
Advertisement
 

RELATED ARTICLES

European Proteomics Infrastructure Consortium – Providing Access

Article

The European Proteomics Infrastructure Consortium providing Access, or EPIC-XS, started in January 2019. It brings together a consortium of world-leading, highly innovative European proteomics facilities with the shared goal of supporting excellent life sciences research in Europe. In this article, Martina O'Flaherty provides an overview of some of the successes of the consortium so far.

READ MORE

COVID-19 Vaccine Safety in Pregnancy

Article

What are the benefits and risks for pregnant persons when it comes to COVID-19 and the vaccines, and does the benefit of the vaccine outweigh the risk of infection? Amber Schmidtke explores the scientific data available.

READ MORE

Examining Risk–Benefit Profiles for Vaccines

Article

In this article, David Elder, explores the risk–benefit profiles for various COVID-19 vaccines and discusses the steps taken by regulatory agencies in response to the occurrence of rare blood clotting events associated with the Oxford–AstraZeneca vaccine.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE